U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik
U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik June 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Edgewise Therapeutics, IBM and Rubrik, on Tuesday.
HIGHLIGHTS
* Edgewise Therapeutics Inc EWTX.O: Raymond James raises target price to $66 from $52 |
* IBM IBM.N: Wedbsuh raises target price to $350 from $320 |
* Praxis Precision Medicines Inc PRAX.O: Baird cuts target price to $400 from $433 |
* Rubrik Inc RBRK.N: Jefferies raises target price to $100 from $65 |
* Vulcan Materials Co VMC.N: Berenberg initiates coverage with hold rating; PT $283 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Aktis Oncology Inc AKTS.O: H.C. Wainwright raises target price to $35 from $33 |
* Allegiant Travel Company ALGT.O: BofA Global Research raises PO to $100 from $90 |
* Alphabet Inc GOOGL.O: HSBC cuts target price to $420 from $435 |
* Ares Commercial Real Estate Corp ACRE.N: UBS raises target price to $5.5 from $5 |
* Arxis Inc ARXS.O: Citigroup raises target price to $50 from $42 |
* Blackstone Mortgage Trust Inc BXMT.N: UBS raises target price to $21 from $20 |
* Blackstone Mortgage Trust Inc BXMT.N: UBS raises to buy from neutral |
* BorgWarner Inc. BWA.N: Wells Fargo raises target price to $83 from $68 |
* Brightspring Health Services BTSG.O: Morgan Stanley raises PT to $71.00 from $62.00 |
* Bruker Corporation BRKR.O: BofA Global Research raises price objective to $65 from $49 |
* Caesars Entertainment Inc CZR.O: Macquarie cuts target price to $31 from $35 |
* Caesars Entertainment Inc CZR.O: Macquarie cuts to neutral from outperform |
* Caesars Entertainment Inc CZR.O: Wells Fargo raises target price to $31 from $26 |
* Campbell's Co CPB.O: UBS cuts target price to $19 from $20 |
* Chewy Inc CHWY.N: JP Morgan cuts target price to $35 from $40 |
* Ciena Corp CIEN.N: B. Riley raises target price to $531 from $283 |
* Conagra Brands Inc CAG.N: UBS cuts target price to $13 from $16 |
* Constellation Energy Corp CEG.O: Raymond James cuts target price to $374 from $392 |
* Edgewise Therapeutics Inc EWTX.O: Raymond James raises target price to $66 from $52 |
* Edwards Lifesciences Corp EW.N: TD Cowen raises target price to $104 from $97 |
* Enliven Therapeutics Inc ELVN.O: Mizuho raises target price to $62 from $45 |
* Fedex FDX.N: BMO cuts target price to $340 from $410 |
* Fedex Corp. FDX.N: BofA Global Research cuts price objective to $376.00 from $440.00 |
* Fedex Freight Holding Co FDXF.N: Truist Securities initiates coverage with hold rating |
* Fedex Freight Holding Co FDXF.N: Truist Securities initiates coverage with PT $155 |
* Five Below FIVE.O: Deutsche Bank raises target price to $298 from $287 |
* Fulcrum Therapeutics FULC.O: H.C. Wainwright cuts target price to $3 from $25 |
* Fulcrum Therapeutics FULC.O: Leerink Partners cuts PT to $4 from $24 |
* Fulcrum Therapeutics FULC.O: Leerink Partners cuts to market perform from outperform |
* Fulcrum Therapeutics FULC.O: Piper Sandler cuts target price to $3 from $23 |
* Fulcrum Therapeutics FULC.O: Piper Sandler cuts to underweight from overweight |
* Fulcrum Therapeutics FULC.O: Stifel cuts to hold from buy; cuts PT to $3 from $25 |
* Fulcrum Therapeutics Inc FULC.O: H.C. Wainwright cuts to neutral from buy |
* Fulcrum Therapeutics Inc FULC.O: Truist Securities cuts target price to $4 from $17 |
* Fulcrum Therapeutics Inc FULC.O: Truist Securities cuts to hold from buy |
* General Mills Inc GIS.N: UBS cuts target price to $30 from $35 |
* Guardant Health Inc GH.O: Evercore ISI raises PT to $160 from $95 |
* Guardant Health Inc GH.O: Evercore ISI raises to outperform from in line |
* Hewlett Packard Enterprise HPE.N: Morgan Stanley raises PT to $71 from $33 |
* Hewlett Packard Enterprise Co HPE.N: Bernstein raises target price to $62 from $35 |
* Hewlett Packard Enterprise Co HPE.N: BofA Global Research raises PO to $80 from $38 |
* Hewlett Packard Enterprise Co HPE.N: Citigroup raises target price to $70 from $39 |
* Hewlett Packard Enterprise Co HPE.N: Evercore ISI raises target price to $70 from $40 |
* Hewlett Packard Enterprise Co HPE.N: JP Morgan raises target price to $68 from $37 |
* Hewlett Packard Enterprise Co HPE.N: Morgan Stanley raises PT to $71 from $33 |
* Hewlett Packard Enterprise Co HPE.N: Piper Sandler raises target price to $63 from $23 |
* Hewlett Packard Enterprise Co HPE.N: Susquehanna raises target price to $65 from $21 |
* Hewlett Packard Enterprise Co HPE.N: Truist Securities raises PT to $69 from $31 |
* Hewlett Packard Enterprise Co HPE.N: UBS raises target price to $65 from $25 |
* Hewlett Packard Enterprise Company HPE.N: Wells Fargo raises PT to $67 from $26 |
* Host Hotels and Resorts, Inc HST.O: UBS raises target price to $23 from $20 |
* IBM IBM.N: Wedbsuh raises target price to $350 from $320 |
* Idex Corporation IEX.N: Oppenheimer raises target price to $250 from $242 |
* Intuitive Surgical ISRG.O: Deutsche Bank cuts target price to $366 from $440 |
* J.M. Smucker Co SJM.N: UBS cuts target price to $121 from $132 |
* Life Time Group Holdings Inc LTH.N: RBC raises target price to $43 from $38 |
* Lineage Inc LINE.O: Morgan Stanley raises target price to $47 from $39 |
* Macerich Co MAC.N: Deutsche Bank raises to buy from hold; raises PT to $27 from $20 |
* Macerich Company MAC.N: Deutsche Bank raises target price to $27 from $20 |
* Macerich Company MAC.N: Deutsche Bank raises to buy from hold |
* Maplight Therapeutics Inc MPLT.O: Stifel raises target price to $36 from $28 |
* Martin Marietta Materials Inc MLM.N: Berenberg initiates coverage with hold rating |
* Martin Marietta Materials Inc MLM.N: Berenberg initiates coverage with PT $556 |
* McCormick & Company Inc MKC.N: UBS cuts target price to $51 from $53 |
* MGM Resorts International MGM.N: Deutsche Bank raises target price to $55 from $48 |
* Mirum Pharmaceuticals Inc MIRM.O: Citigroup initiates coverage with buy rating; PT $145 |
* Mobia Medical Inc MOBI.O: BofA Global Research initiates coverage with buy rating |
* Mobia Medical Inc MOBI.O: BofA Global Research initiates coverage with PO $16.00 |
* Mobia Medical Inc MOBI.O: BTIG initiates coverage with buy rating; price target $19 |
* Mobia Medical Inc MOBI.O: JP Morgan initiates coverage with overweight rating; PT $15 |
* Navan Inc NAVN.O: TD Cowen raises target price to $28 from $19 |
* Octave Intelligence Plc OCTV.O: RBC initiates coverage with sector perform rating |
* Octave Intelligence Plc OCTV.O: RBC initiates coverage with target price $21 |
* Odyssey Therapeutics Inc ODTX.O: TD Cowen initiates coverage with buy rating |
* Odyssey Therapeutics Inc ODTX.O: Wedbush initiates coverage with outperform rating; PT $30 |
* Oracle Corp ORCL.N: Scotiabank raises target price to $290 from $215 |
* Oracle Corp ORCL.N: UBS raises target price to $285 from $250 |
* Oxford Industries Inc OXM.N: UBS raises target price to $42 from $33 |
* Penguin Solutions Inc PENG.O: Rosenblatt Securities raises PT to $65 from $54 |
* Penguin Solutions Inc PENG.O: Stifel raises target price to $66 from $24 |
* Praxis Precision Medicines Inc PRAX.O: Baird cuts target price to $400 from $433 |
* Praxis Precision Medicines Inc PRAX.O: Raymond James cuts PT to $765 from $815 |
* Praxis Precision Medicines Inc PRAX.O: TD Cowen cuts target price to $510 from $554 |
* Praxis Precision Medicines Inc PRAX.O: Truist Securities cuts PT to $616 from $715 |
* Praxis Precision Medicines, Inc. PRAX.O: Deutsche Bank cuts PT to $374 from $420 |
* Praxis Precision Medicines, Inc. PRAX.O: H.C. Wainwright cuts PT to $1,201 from $1,245 |
* Progyny PGNY.O: BofA Global Research raises price objective to $31.00 from $29.00 |
* Revolution Medicines Inc RVMD.O: RBC raises target price to $182 from $165 |
* Rubrik Inc RBRK.N: Jefferies raises target price to $100 from $65 |
* Sable Offshore Corp SOC.N: Gerdes Energy Research cuts target price by $4 to $13 |
* Sable Offshore Corp SOC.N: Gerdes Energy Research cuts to neutral from buy |
* Sailpoint Inc SAIL.O: Barclays raises target price to $22 from $16 |
* Science Applications International SAIC.O: Truist Securities raises PT to $110 from $95 |
* Science Applications International Corp SAIC.O: JP Morgan raises PT to $125 from $110 |
* Seven Hills Realty Trust SEVN.O: UBS initiates coverage with buy rating and PT $10 |
* Sezzle Inc SEZL.O: B. Riley raises target price to $141 from $117 |
* Sherwin-Williams Co SHW.N: UBS cuts target price to $330 from $385 |
* Sherwin-Williams Co SHW.N: UBS cuts to neutral from buy |
* Simply Good Foods Co SMPL.O: UBS cuts target price to $12 from $13 |
* Standardaero Inc SARO.N: Jefferies cuts target price to $30 from $34 |
* Standardaero Inc SARO.N: Jefferies cuts to hold from buy |
* Starwood Property Trust Inc (Maryland) STWD.N: UBS raises PT to $20 from $19.5 |
* Starwood Property Trust Inc (Maryland) STWD.N: UBS raises to buy from neutral |
* Strive Inc ASST.O: Benchmark initiates coverage with buy rating; target price $32 |
* Take-Two Interactive Software TTWO.O: Piper Sandler initiates coverage with overweight rating |
* Take-Two Interactive Software TTWO.O: Piper Sandler initiates coverage with PT $280 |
* Taylor Morrison Home Corp TMHC.N: RBC cuts to sector perform from outperform |
* Taylor Morrison Home Corp TMHC.N: Truist Securities cuts to hold from buy |
* Unity Software Inc U.N: Piper Sandler raises target price to $40 from $35 |
* Veradermics Inc MANE.N: Needham initiates coverage with buy rating; PT $136 |
* Visteon Corp VC.O: Wells Fargo raises target price to $139 from $125 |
* Vulcan Materials Co VMC.N: Berenberg initiates coverage with hold rating; PT $283 |
* Waters Corp WAT.N: BofA Global Research raises price objective to $400 from $370 |
* Western Digital Corp WDC.O: Citigroup raises target price to $685 from $500 |
* X4 Pharmaceuticals XFOR.O: Leerink Partners initiates coverage with outperform rating |
* X4 Pharmaceuticals XFOR.O: Leerink Partners initiates coverage with price target $12 |
* Zoom Communications Inc ZM.O: HSBC raises target price to $133 from $107 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Recent news on Vulcan Materials Co
See all newsS&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik
Brief: DOJ says it requires Taiheiyo Cement, Calportland to divest assets to proceed with deal
Vulcan Materials beats revenue estimates on strong demand for construction materials
Vulcan Q1 revenue beats estimates on shipment growth